⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US
businesswire.com
AZN
Reset Health Further Strengthens Advisory Board With Appointment of Pinder Sahota
globenewswire.com
NVO
AZN
GSK
Eccogene Announces Positive Topline Results from Phase 1b Trial of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, in Adult Participants Living with Obesity/Overweight, with or without Type 2 Diabetes in China
businesswire.com
AZN
Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market
prnewswire.com
HELP
TAK
AZN
JNJ
ABBV
AstraZeneca results: FY and Q4 2025
businesswire.com
AZN
BMY
Claudin 18.2 Targeted Therapy Market Research 2026: Astellas' Zolbetuximab Leads Gastric Cancer Progress, While Servier Pharmaceuticals and Others Expand ADC and CAR-T Strategies - Forecasts to 2030
globenewswire.com
AZN
BNTX
$12 Bn Private LTE/5G Network Market Forecasts, 2025-2026 & 2030: Insights from 35 New Executive Interviews with Market Leading Companies
globenewswire.com
ERIC
NOK
MSFT
AMZN
SWKS
AVGO
QCOM
INTC
CSCO
HPE
SNPS
AMAT
LRCX
KLAC
ASML
MU
WDC
SE
NVDA
AMD
MRVL
NXPI
QRVO
ON
ADI
TXN
MCHP
INFY
IBM
ORCL
SAP
ACN
CTAS
CDNS
GLW
AVNT
ATOS
NTES
BABA
JD
PDD
IQ
BIDU
HTHT
BILI
VIPS
NIO
LI
XPEV
RIVN
LCID
TSLA
F
GM
STLA
CHPT
PLTR
SNOW
DDOG
CRM
NOW
PANW
FTNT
ZS
CRWD
MDB
PYPL
COIN
UPST
SOFI
AFRM
HOOD
ETSY
GOOG
HPQ
DELL
SMCI
ALGN
IDXX
REGN
VRTX
GILD
AMGN
BMY
PFE
MRK
JNJ
ABBV
LLY
BIIB
AZN
SNY
TEVA
BMRN
EXPE
BKNG
MAR
H
IHG
WYNN
LVS
MGM
CCL
RCL
NCLH
AAL
DAL
UAL
LUV
BA
GD
LMT
RTX
HON
CAT
DE
GE
MMM
ROK
EMR
ILMN
MELI
ADBE
GOOGL
AAPL
T
VZ
TMUS
CMCSA
CHTR
Life Sciences Analytics Market Advances to US$ 23.17 Billion by 2033 on AI-Driven Drug Discovery and Cloud Platforms Says Astute Analytica
globenewswire.com
JNJ
AZN
MRK
ORCL
IQV
PFE
NVS
TAK
BMY
SNY
LLY
GILD
ACN
DLTR
IBM
Cell and Gene Therapy in Numbers: $1.2B in Zolgensma Sales, $1.5B Yescarta Revenue, 46 FDA-Approved Therapies and $2B Strategic Deals
globenewswire.com
NVS
GILD
BMY
REGN
CRSP
NTLA
EDIT
BBIO
AZN
SGMO
Primmune Therapeutics Appoints Chief Medical Officer and Executive Board Chair; Establishes Melanoma Clinical Study Advisory Board
globenewswire.com
ALGN
AZN
EXEL
VRTX
XNCR